Skip to main content
Log in

Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In a double-blind, randomized crossover study, the hypotheses were tested that more powerful inhibition of gastric acid secretion by adjuvant omeprazole further improves the efficacy of pancreatic enzyme replacement therapy compared to adjuvant cimetidine and that excluding the influence of pH-related factors, by virtually complete inhibition of gastric acid secretion with 60 mg omeprazole daily, does not lead to total elimination of steatorrhea. During both adjuvant cimetidine and omeprazole treatment, fecal fat excretion was significantly lower compared to pancreatin monotherapy (P<0.01). Omeprazole showed a trend towards a more favorable decrease of fecal fat excretion compared to cimetidine but no statistically significant difference. Steatorrhea was almost never abolished, even during 60 mg omeprazole daily. Generally, pH-related factors are considered to explain an inadequate therapeutic response during pancreatic enzyme replacement therapy. However, this study indicates thatin vivo other factors also play a significant role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Heizer WD, Cleaveland CR, Iber FL: Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270, 1965

    PubMed  Google Scholar 

  2. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL: Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858, 1977

    PubMed  Google Scholar 

  3. DiMagno EP, Malagelada JR, Go VL, Moertel CG: Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 296:1318–1322, 1977

    PubMed  Google Scholar 

  4. DiMagno EP: Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 27:481–484, 1982

    PubMed  Google Scholar 

  5. Stead RJ, Skypala I, Hodson ME: Treatment of steatorrhea in cystic fibrosis: A comparison of enteric coated microspheres of pancreatin versus non-enteric coated pancreatin and adjuvant cimetidine. Aliment Pharmacol Ther 2:471–482, 1988

    PubMed  Google Scholar 

  6. Marotta F, O'Keefe SJD, Marks IN, Girdwood A, Young G: Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig Dis Sci 34:456–461, 1989

    PubMed  Google Scholar 

  7. Lankisch PG, Lembcke B, Goke B, Creutzfeldt W: Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 24:753–757, 1986

    PubMed  Google Scholar 

  8. Carroccio A, Pardo F, Montalto G, Iapichino L, Soresi M, Averna MR, Iacono G, Notarbartolo A: Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis. Dig Dis Sci 37:1441–1446, 1992

    PubMed  Google Scholar 

  9. Heijerman HG, Lamers CB, Bakker W: Omeprazole enhances the efficacy of pancreatin (Pancrease) in cystic fibrosis. Ann Intern Med 114:200–201, 1991

    PubMed  Google Scholar 

  10. Walt RP, Gomes MDFA, Wood EC, Logan LH, Pounder RE: Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J 287:12–14, 1983

    Google Scholar 

  11. Naesdal J, Bodemar G, Walan A: Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 19:916–922, 1984

    PubMed  Google Scholar 

  12. Olbe L, Lind T, Cederberg C, Ekenved G: Effect of omeprazole on gastric acid secretion in man. Scand J Gastroenterol Suppl 21:105–107, 1986

    Google Scholar 

  13. Van de Kamer JH, Bokkel Huinink ten H, Weyers HA: Rapid method for the determination of fat in feces. J Biol Chem 177:347–355, 1949

    Google Scholar 

  14. Andersen JR, Bendtsen F, Ovesen L, Pedersen NT, Rune SJ, Tage Jensen U: Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. Int J Pancreatol 6:263–270, 1990

    PubMed  Google Scholar 

  15. Regan PT, Malagelada JR, DiMagno EP, Go VL: Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology 77:285–289, 1979

    PubMed  Google Scholar 

  16. Zentler Munro PL, Fine DR, Batten JC, Northfield TC: Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Gut 26:892–901, 1985

    PubMed  Google Scholar 

  17. Cabral DJ, Small DM: Physical chemistry of bile.In Handbook of Physiology. A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts. Section 6, The Gastrointestinal System. SG Schultz, JG Forte, BB Rauner (eds). Bethesda, American Physiological Society, 1989, pp 621–662

    Google Scholar 

  18. Dutta SK, Anand K, Gadacz TR: Bile salt malabsorption in pancreatic insufficiency secondary to alcoholic pancreatitis. Gastroenterology 91:1243–1249, 1986

    PubMed  Google Scholar 

  19. Graham DY: Pancreatic enzyme replacement. The effect of antacids or cimetidine. Dig Dis Sci 27:485–490, 1982

    PubMed  Google Scholar 

  20. Graham DY: Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. N Engl J Med 296:1314–1317, 1977

    PubMed  Google Scholar 

  21. Bank S, Marks IN, Groll A: Gastric acid secretion in pancreatic disease. Gastroenterology 51:649–655, 1966

    PubMed  Google Scholar 

  22. Gupta S, Rao TR: Gastric acid secretion in pancreatic disease. Digestion 12:189–191, 1975

    PubMed  Google Scholar 

  23. Regan PT, Malagelada JR, DiMagno EP, Go VL: Postprandial gastric function in pancreatic insufficiency. Gut 20:249–254, 1979

    PubMed  Google Scholar 

  24. Saunders JH, Cargill JM, Wormsley KG: Gastric secretion of acid in patients with pancreatic disease. Digestion 17:365–369, 1978

    PubMed  Google Scholar 

  25. Cox KL, Isenberg JN: Hypersecretion of gastric acid in patients with pancreatic exocrine insufficiency due to cystic fibrosis. Gastroenterology 74:1022, 1978

    Google Scholar 

  26. Gullo L, Corinaldesi R, Casadio R, Vezzadini P, Tomassetti P, Ventrucci M, Priori P, Labo G: Gastric acid secretion in chronic pancreatitis. Hepato-Gastroenterol 30:60–62, 1983

    Google Scholar 

  27. Dutta SK, Russell RM, Iber FL: Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529–534, 1979

    PubMed  Google Scholar 

  28. Ovesen L, Bendtsen F, Tage Jensen U, Pedersen NT, Gram BR, Rune SJ: Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90:958–962, 1986

    PubMed  Google Scholar 

  29. Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W: Functional reserve capacity of the exocrine pancreas. Digestion 35:175–181, 1986

    PubMed  Google Scholar 

  30. Thiruvengadam R, DiMagno EP: Inactivation of human lipase by proteases. Am J Physiol 255 (Gastrointest Liver Physiol 18):G476-G481, 1988

    PubMed  Google Scholar 

  31. Thiruvengadam R, Sandberg R, Bentley K, DiMagno EP: Why does lipase activity decrease during aboral small intestinal transit in humans? Gastroenterology 90:1663, 1986 (abstract)

    Google Scholar 

  32. Borgström B, Erlanson C: Pancreatic juice co-lipase. Physiological importance. Biochim Biophys Acta 242:509–513, 1971

    PubMed  Google Scholar 

  33. Kelly DG, Bentley KJ, Sarles H, Zinsmeister AR, DiMagno EP: Do nutrients and bile in human duodenal juice affect the survival of lipase activity? Possible clinical implications. Gastroenterology 94:A222, 1988 (abstract)

    Google Scholar 

  34. Dutta SK, Hlasko J: Dietary fiber in pancreatic disease. Effect of high fiber diet on fat malabsorption in pancreatic insufficiency andin vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr 41:517–525, 1985

    PubMed  Google Scholar 

  35. Morin CL, Roy CC, Lasalle R, Bonin A: Small bowel mucosal dysfunction in patients with cystic fibrosis. J Pediatr 88:213–216, 1976

    PubMed  Google Scholar 

  36. Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P: Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92:125–129, 1987

    PubMed  Google Scholar 

  37. Moreau J, Bouisson M, Balas D, Ravaud A, Stupnik S, Buscail L, Vaysse N, Ribet A: Gastric lipase in alcoholic pancreatitis. Comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency. Gastroenterology 99:175–180, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruno, M.J., Rauws, E.A.J., Hoek, F.J. et al. Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy. Digest Dis Sci 39, 988–992 (1994). https://doi.org/10.1007/BF02087549

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087549

Key words

Navigation